Matches in Wikidata for { <http://www.wikidata.org/entity/Q64150938> ?p ?o ?g. }
Showing items 1 to 41 of
41
with 100 items per page.
- Q64150938 description "clinical trial" @default.
- Q64150938 description "ensayu clínicu" @default.
- Q64150938 description "klinisch onderzoek" @default.
- Q64150938 description "клінічне випробування" @default.
- Q64150938 description "կլինիկական փորձարկում" @default.
- Q64150938 name "Efficacy, Safety and Pharmacokinetics Study of Kedrion IVIG 10% to Treat Participants With Primary Immunodeficiency (PID)" @default.
- Q64150938 type Item @default.
- Q64150938 label "Efficacy, Safety and Pharmacokinetics Study of Kedrion IVIG 10% to Treat Participants With Primary Immunodeficiency (PID)" @default.
- Q64150938 prefLabel "Efficacy, Safety and Pharmacokinetics Study of Kedrion IVIG 10% to Treat Participants With Primary Immunodeficiency (PID)" @default.
- Q64150938 P1132 Q64150938-615DB950-A5E7-4827-B6E1-B4B57338C608 @default.
- Q64150938 P1476 Q64150938-65B24FEA-B23B-4DF4-97E0-5A715792D9A6 @default.
- Q64150938 P17 Q64150938-74A64F17-3D0E-4020-B901-11D122C42066 @default.
- Q64150938 P17 Q64150938-C72BFCA5-BDCA-469F-9A70-CE9A7B53CD5A @default.
- Q64150938 P2899 Q64150938-EFD854D7-66F4-4C2F-A3D7-DAE2AC99C469 @default.
- Q64150938 P3098 Q64150938-1C3D539C-6FB3-4888-B41E-4269EA627504 @default.
- Q64150938 P31 Q64150938-72439B0C-58AE-4DC4-B1CA-BEDFB189B858 @default.
- Q64150938 P4135 Q64150938-E2882BFC-1073-4A8A-92F9-1E217FEB6166 @default.
- Q64150938 P580 Q64150938-69B49A49-47BF-4B7A-B31F-B1C3B2881B4A @default.
- Q64150938 P582 Q64150938-47CA8192-C20F-4CAB-90F6-6E1D3186E9D7 @default.
- Q64150938 P6099 Q64150938-A2F485E2-19FE-416F-9675-38CA013B81FF @default.
- Q64150938 P6153 Q64150938-1F4F99D5-718B-4BAC-AEA0-28D4F17E76D9 @default.
- Q64150938 P6153 Q64150938-572C9C8C-DAA8-4E1D-85D0-C9C9A3276D5B @default.
- Q64150938 P6153 Q64150938-5EDC7D1E-E88E-4C93-9EE2-1CB935087A79 @default.
- Q64150938 P6153 Q64150938-AE720D37-2144-4048-B2A6-44FC4CCEC0E7 @default.
- Q64150938 P8363 Q64150938-5E31B9A3-E74A-4548-96E0-63561500FAF5 @default.
- Q64150938 P1132 "+50" @default.
- Q64150938 P1476 "A Phase III, Open-label, Prospective, Multicenter Study to Assess Efficacy, Safety and Pharmacokinetics of Kedrion Intravenous Immunoglobulin (IVIg) 10% in Primary Immunodeficiency Disease (PID) Patients" @default.
- Q64150938 P17 Q16 @default.
- Q64150938 P17 Q30 @default.
- Q64150938 P2899 "+2" @default.
- Q64150938 P3098 "NCT03961009" @default.
- Q64150938 P31 Q30612 @default.
- Q64150938 P4135 "+70" @default.
- Q64150938 P580 "2019-04-30T00:00:00Z" @default.
- Q64150938 P582 "2021-02-16T00:00:00Z" @default.
- Q64150938 P6099 Q42824827 @default.
- Q64150938 P6153 Q1535116 @default.
- Q64150938 P6153 Q30269554 @default.
- Q64150938 P6153 Q640694 @default.
- Q64150938 P6153 Q681025 @default.
- Q64150938 P8363 Q78089383 @default.